Literature DB >> 11445587

A yeast four-hybrid system identifies Cdk-activating kinase as a regulator of the XPD helicase, a subunit of transcription factor IIH.

B Sandrock1, J M Egly.   

Abstract

To understand the role of the various components of TFIIH, a DNA repair/transcription factor, a yeast four-hybrid system was designed. When the ternary Cdk-activating kinase (CAK) complex composed of Cdk7, cyclin H, and MAT1 was used as bait, the xeroderma pigmentosum (XP) D helicase of transcription factor IIH (TFIIH), among other proteins, was identified as an interacting partner. Deletion mutant analyses demonstrated that the coiled-coil and the hydrophobic domains of MAT1 interlink the CAK complex directly with the N-terminal domain of XPD. Using immunoprecipitates from cells coinfected with baculoviruses, we further validated the bridging function of XPD, which anchors CAK to the core TFIIH. In addition we show that upon interaction with MAT1, CAK inhibits the helicase activity of XPD. This inhibition is overcome upon binding to p44, a subunit of the core TFIIH. It is not surprising that under these conditions some XPD mutations affect interactions not only with p44, but also with MAT1, thus preventing either the CAK inhibitory function within CAK.XPD and/or the role of CAK within TFIIH and, consequently, explaining the variety of the XP phenotypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11445587     DOI: 10.1074/jbc.M105570200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Subunit architecture of general transcription factor TFIIH.

Authors:  Brian J Gibbons; Edward J Brignole; Maia Azubel; Kenji Murakami; Neil R Voss; David A Bushnell; Francisco J Asturias; Roger D Kornberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

Review 2.  Other proteins interacting with XP proteins.

Authors:  Steven M Shell; Yue Zou
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 3.  TFIIH: when transcription met DNA repair.

Authors:  Emmanuel Compe; Jean-Marc Egly
Journal:  Nat Rev Mol Cell Biol       Date:  2012-05-10       Impact factor: 94.444

Review 4.  Orchestral maneuvers at the damaged sites in nucleotide excision repair.

Authors:  Sergey Alekseev; Frédéric Coin
Journal:  Cell Mol Life Sci       Date:  2015-02-15       Impact factor: 9.261

Review 5.  XPB and XPD helicases in TFIIH orchestrate DNA duplex opening and damage verification to coordinate repair with transcription and cell cycle via CAK kinase.

Authors:  Jill O Fuss; John A Tainer
Journal:  DNA Repair (Amst)       Date:  2011-05-14

6.  Crystal structure of the Rad3/XPD regulatory domain of Ssl1/p44.

Authors:  Jin Seok Kim; Charlotte Saint-André; Hye Seong Lim; Cheol-Sang Hwang; Jean Marc Egly; Yunje Cho
Journal:  J Biol Chem       Date:  2015-02-13       Impact factor: 5.157

7.  Corepressor MMTR/DMAP1 is involved in both histone deacetylase 1- and TFIIH-mediated transcriptional repression.

Authors:  Bong Gu Kang; June Ho Shin; Jae Kyu Yi; Ho Chul Kang; Jong Joo Lee; Hyen Seok Heo; Ji Hyung Chae; Incheol Shin; Chul Geun Kim
Journal:  Mol Cell Biol       Date:  2007-03-19       Impact factor: 4.272

8.  ARCH domain of XPD, an anchoring platform for CAK that conditions TFIIH DNA repair and transcription activities.

Authors:  Wassim Abdulrahman; Izarn Iltis; Laura Radu; Cathy Braun; Anne Maglott-Roth; Christophe Giraudon; Jean-Marc Egly; Arnaud Poterszman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

9.  Drosophila Xpd regulates Cdk7 localization, mitotic kinase activity, spindle dynamics, and chromosome segregation.

Authors:  Xiaoming Li; Olivier Urwyler; Beat Suter
Journal:  PLoS Genet       Date:  2010-03-12       Impact factor: 5.917

10.  On the traces of XPD: cell cycle matters - untangling the genotype-phenotype relationship of XPD mutations.

Authors:  Elisabetta Cameroni; Karin Stettler; Beat Suter
Journal:  Cell Div       Date:  2010-09-15       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.